Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction

被引:57
作者
CallesEscandon, J
Ballor, D
HarveyBerino, J
Ades, P
Tracy, R
Sobel, B
机构
[1] UNIV VERMONT, COLL MED, DEPT INTERNAL MED, BURLINGTON, VT 05405 USA
[2] UNIV VERMONT, COLL MED, DEPT HUMAN DEV STUDIES, BURLINGTON, VT 05405 USA
[3] UNIV VERMONT, COLL MED, DEPT FOOD SCI & HUMAN NUTR, BURLINGTON, VT 05405 USA
[4] UNIV VERMONT, COLL MED, DEPT PATHOL, BURLINGTON, VT 05405 USA
[5] UNIV VERMONT, COLL MED, DEPT BIOCHEM, BURLINGTON, VT 05405 USA
关键词
atherosclerosis; obesity; coronary disease; elderly people; PLASMINOGEN-ACTIVATOR INHIBITOR; LINKED IMMUNOSORBENT-ASSAY; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; FACTOR-VII; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; ABDOMINAL OBESITY; VENOUS OCCLUSION; SEDENTARY MEN;
D O I
10.1093/ajcn/64.1.7
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
A possible cause of accelerated atherothrombosis in the syndrome of insulin resistance appears to be an elevated blood concentration of Plasminogen activator inhibitor type-1 (PAI-1). Insulin resistance occurs with aging, attributable partly to increased adiposity. Scarce information exists regarding the effects of weight loss in elderly, obese individuals on PAI-1 concentrations. Consequently, weight loss (9 +/- 1 kg) was induced by energy intake restriction in 19 elderly, obese individuals, and its effect on fibrinolytic system peptides was measured. Initially elevated PAI-1 concentrations decreased by 50%, with a simultaneous decrease in the concentration of tissue-type plasminogen activator (t-PA)/PAI-1 complexes but no significant change in t-PA suggested a decrease in inhibition of the fibrinolytic system. The concentration of plasmin/antiplasmin complexes (PAP complex) increased by approximate to 20%, indicating augmented fibrinolytic system activity. The decline in PAI-1 correlated with that of the decrease in body weight (r = 0.5, P < 0.05) and fat mass losses (r = 0.46, P < 0.05). The increase in PAP complexes correlated with weight and fat mass losses (r = 0.4 and r = 0.46, respectively; P < 0.05 for both). No correlation was seen between fibrinolytic system variables and baseline concentrations of substrates or insulin, but the change in PAI-1 correlated with the change in plasma triacylglycerols (r = 0.58, P < 0.05). Results indicate that energy restriction sufficient to induce moderate weight loss leads to diminution of elevated plasma PAI-1 and relief of inhibition of the fibrinolytic system in elderly, obese subjects. To the extent that these changes are associated with a decrease in the progression of vasculopathy, weight loss in elderly, obese individuals may be a useful means to reduce cardiovascular morbidity and mortality.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 53 条
  • [1] CORRELATIONS BETWEEN T-PA AND PAI-1 ANTIGEN AND ACTIVITY AND T-PA/PAI-1 COMPLEXES IN PLASMA OF CONTROL SUBJECTS AND OF PATIENTS WITH INCREASED T-PA OR PAI-1 LEVELS
    ALESSI, MC
    JUHANVAGUE, I
    DECLERCK, PJ
    ANFOSSO, F
    GUEUNOUN, E
    COLLEN, D
    [J]. THROMBOSIS RESEARCH, 1990, 60 (06) : 509 - 516
  • [2] RELATIONSHIP BETWEEN PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY AND VLDL TRIGLYCERIDE CONCENTRATION, INSULIN LEVELS AND INSULIN SENSITIVITY - STUDIES IN RANDOMLY SELECTED NORMOTRIGLYCERIDAEMIC AND HYPERTRIGLYCERIDEMIC MEN
    ASPLUNDCARLSON, A
    HAMSTEN, A
    WIMAN, B
    CARLSON, LA
    [J]. DIABETOLOGIA, 1993, 36 (09) : 817 - 825
  • [3] TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS
    AUWERX, J
    BOUILLON, R
    COLLEN, D
    GEBOERS, J
    [J]. ARTERIOSCLEROSIS, 1988, 8 (01): : 68 - 72
  • [4] EFFECT OF WEIGHT-LOSS ON COAGULATION FACTOR-VII AND FACTOR-X
    BARON, JA
    MANN, J
    STUKEL, T
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (08) : 519 - 522
  • [5] EFFECTS OF AGE AND BODY-FAT ON INSULIN RESISTANCE IN HEALTHY-MEN
    BODEN, G
    CHEN, XH
    DESANTIS, RA
    KENDRICK, Z
    [J]. DIABETES CARE, 1993, 16 (05) : 728 - 733
  • [6] INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY
    CORTELLARO, M
    COFRANCESCO, E
    BOSCHETTI, C
    MUSSONI, L
    DONATI, MB
    CARDILLO, M
    CATALANO, M
    GABRIELLI, L
    LOMBARDI, B
    SPECCHIA, G
    TAVAZZI, L
    TREMOLI, E
    POZZOLI, E
    TURRI, M
    CORTELLARO, M
    COFRANCESCO, E
    BOSCHETTI, C
    CARDILLO, M
    TORRI, M
    RAINISIO, M
    GENTILE, G
    MOREO, G
    BIANCHI, O
    LEONARDI, P
    COLOMBI, M
    CATALANO, M
    GALIMBERTI, P
    RUSSO, U
    CRESSOTTI, A
    CARZANIGA, G
    NOBILI, S
    NINNO, D
    DONATI, MB
    IACOVIELLO, L
    DEGAETANO, G
    GABRIELLI, L
    MARTELLI, E
    CORSI, G
    LORENZI, G
    LOMBARDI, B
    CARRIERO, MR
    COLOMBO, R
    SPECCHIA, G
    CIOFFI, P
    SCIRE, A
    TAVAZZI, L
    GIANNUZZI, P
    CORRA, U
    TEMPORELLI, L
    MORA, F
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10): : 1412 - 1417
  • [7] DECLERCK PJ, 1988, BLOOD, V71, P220
  • [8] INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE
    DEFRONZO, RA
    FERRANNINI, E
    [J]. DIABETES CARE, 1991, 14 (03) : 173 - 194
  • [9] FIBRINOGEN IN OBESITY BEFORE AND AFTER WEIGHT-REDUCTION
    DITSCHUNEIT, HH
    FLECHTNERMORS, M
    ADLER, G
    [J]. OBESITY RESEARCH, 1995, 3 (01): : 43 - 48
  • [10] ERNST E, 1989, INT J OBESITY, V13, P167